Safety of once‐daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents in routine clinical practice

ConclusionsOnce‐daily insulin detemir therapy was safe and effective, and rates of hypoglycemia were low. Concerns about hypoglycemia should not deter the initiation of basal insulin analogs.

Source: Journal of Diabetes - October 29, 2013 Category: Endocrinology Authors: Stuart Ross, Grzegorz Dzida, Qiuhe Ji, Marcel Kaiser, Robert Ligthelm, Luigi Meneghini, Avideh Nazeri, Domingo Orozco‐Beltran, Changyu Pan, Anne Louise Svendsen, Tags: Original Article Source Type: research